Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	13.29	57.70	50.93
Graham Fair Price	< 0.005	3.73	3.73
PEG	inf	0.00	-0.38
Price/Book	11.82	1.95	1.75
Price/Cash Flow	11.82	60.97	54.52
Prices/Earnings	11.82	31.57	28.24
Price/Sales	11.82	17.81	15.93
Price/FCF	11.82	60.97	54.52
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.73	0.73
Operating Margin	0.00	0.25	0.25
ROA	0.00	0.01	0.01
ROE	0.02	0.02	< 0.005
ROIC	0.02	0.02	0.01
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	-0.01	90.30
Dividends QOQ	0.30	0.00	inf
EBIT QOQ	-0.55	0.00	inf
EPS QOQ	-0.75	0.00	inf
FCF QOQ	-0.33	0.00	inf
Revenue QOQ	-0.26	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	123.00	123.00	0.00
Days Sales Outstanding (DSO)	91.81	91.81	0.00
Inventory Turnover	0.73	0.73	0.00
Debt/Capitalization	0.08	0.08	-0.13
Quick Ratio	3.85	3.85	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	6.33	6.33	< 0.005
Cash	2.51	2.51	0.00
Capex	< 0.005	< 0.005	0.00
Free Cash Flow	0.20	0.20	0.00
Revenue	0.69	0.69	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	4.29	4.29	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-6.36	-6.36	-0.06
Naive Interpretation	Member

06 - Financial Health · Bad

Rating